Record NNP B-NP O
date NN I-NP O
: : O O
2079-03-28 CD O B-DATE
Other JJ B-NP O
CARDIOLOGY NNP I-NP O
F8 CD I-NP O
- : O O
INTERN NN B-NP O
ADMIT NNP I-NP O
NOTE NNP I-NP O
Hosptial NNP B-NP O
Room NNP I-NP O
: : O O
Attending VBG B-VP O
: : O O
Carroll NNP B-NP B-DOCTOR
( -LRB- I-NP O
Cardiology NN I-NP O
) -RRB- O O
PCP NNP B-NP O
: : O O
Smith NNP B-VP B-DOCTOR
( -LRB- B-NP O
Internal JJ I-NP O
Medicine NN I-NP O
) -RRB- O O
Speciailists NNS B-NP O
: : O O
Carroll NNP B-NP B-DOCTOR
( -LRB- I-NP O
Cardiology) NNP I-NP O
Chief NNP I-NP O
Complaint NNP I-NP O
Abnormal NNP I-NP O
stress NN I-NP O
testHistory NN I-NP O
of IN B-PP O
Present NNP B-NP O
Illness NNP I-NP O
55 CD I-NP B-AGE
yo NNP I-NP O
M NNP I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
IDDM NNP B-NP O
, , O O
hypertension NN B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
ESRD NNP B-NP O
( -LRB- I-NP O
on IN B-PP O
HD) NNP B-NP O
, , O O
h/o NN B-NP O
DVT NN I-NP O
( -LRB- I-NP O
positive JJ I-NP O
lupus NN I-NP O
anticoagulant NN I-NP O
) -RRB- I-NP O
, , O O
osteoarthritis NN B-NP O
was VBD B-VP O
scheduled VBN I-VP O
for IN B-PP O
elective NN B-NP O
hip NN I-NP O
surgery NN I-NP O
3/29/77 CD B-NP B-DATE
. . O O
For IN B-PP O
his PRP$ B-NP O
pre-operative JJ I-NP O
work-up NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
stress NN I-NP O
PET NN I-NP O
exam NN I-NP O
on IN B-PP O
3/26 CD B-NP B-DATE
that WDT B-NP O
was VBD B-VP O
notable JJ B-ADJP O
for IN B-PP O
a DT B-NP O
medium-sized JJ I-NP O
defect NN I-NP O
of IN B-PP O
moderate JJ B-NP O
intensity NN I-NP O
in IN B-PP O
the DT B-NP O
mid JJ I-NP O
and CC I-NP O
basal JJ I-NP O
inferior JJ I-NP O
and CC I-NP O
inferolateral JJ I-NP O
walls NNS I-NP O
that WDT B-NP O
was VBD B-VP O
reversible JJ B-ADJP O
. . O O
As IN B-PP O
a DT B-NP O
result NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
referred VBN I-VP O
to TO B-PP O
Dr. NNP B-NP O
Carroll NNP I-NP B-DOCTOR
who WP B-NP O
saw VBD B-VP O
the DT B-NP O
patient NN I-NP O
in IN B-PP O
clinic NN B-NP O
on IN B-PP O
3/27 CD B-NP B-DATE
. . O O
Given VBN B-VP O
the DT B-NP O
patient NN I-NP O
's POS B-NP O
risk NN I-NP O
factors NNS I-NP O
and CC O O
positive JJ B-NP O
stress NN I-NP O
test NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
scheduled VBN I-VP O
for IN B-PP O
right NN B-NP O
and CC O O
left VBD B-VP O
heart NN B-NP O
catheterization NN I-NP O
on IN B-PP O
the DT B-NP O
day NN I-NP O
of IN B-PP O
admission NN B-NP O
with IN B-PP O
the DT B-NP O
plan NN I-NP O
to TO B-VP O
delay VB I-VP O
his PRP$ B-NP O
hip NN I-NP O
surgery NN I-NP O
if IN B-SBAR O
he PRP B-NP O
requires VBZ B-VP O
a DT B-NP O
stent JJ I-NP O
and CC I-NP O
subsequent JJ I-NP O
Plavix NNP I-NP O
therapy NN I-NP O
. . O O
On IN B-PP O
the DT B-NP O
evening NN I-NP O
prior RB B-ADVP O
to TO B-PP O
his PRP$ B-NP O
catheterization NN I-NP O
, , O O
he PRP B-NP O
had VBD B-VP O
dialysis NN B-NP O
. . O O
The DT B-NP O
patient NN I-NP O
went VBD B-VP O
to TO B-PP O
the DT B-NP O
cath NN I-NP O
lab NN I-NP O
where WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
an DT B-NP O
80 CD I-NP O
% NN I-NP O
lesion NN I-NP O
of IN B-PP O
the DT B-NP O
mid-RCA NN I-NP O
so IN B-PP O
a DT B-NP O
bare-metal JJ I-NP O
stent NN I-NP O
was VBD B-VP O
placed VBN I-VP O
. . O O
After IN B-PP O
cath NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
ASA NNP B-NP O
325mg CD I-NP O
PO NNP I-NP O
daily JJ I-NP O
and CC I-NP O
Plavix NNP I-NP O
loaded VBD B-VP O
with IN B-PP O
600mg JJ B-NP O
PO NNP I-NP O
x NN I-NP O
1 CD B-NP O
then RB I-NP O
75mg CD I-NP O
PO NN I-NP O
daily JJ I-NP O
thereafter RB B-ADVP O
. . O O
He PRP B-NP O
was VBD B-VP O
also RB I-VP O
given VBN I-VP O
Warfarin NNP B-NP O
8mg CD I-NP O
PO NNP I-NP O
x NN I-NP O
1 CD I-NP O
for IN B-PP O
an DT B-NP O
INR NN I-NP O
of IN B-PP O
1.6.Review CD B-NP O
of IN B-PP O
Systems NNPS B-NP O
negative JJ I-NP O
except IN B-PP O
as IN B-PP O
abovePast JJ B-NP O
Medical NNP I-NP O
History NNP I-NP O
1 CD I-NP O
. . O O
IDDM NNP O O
( -LRB- O O
A1c NNP B-NP O
6.9 CD I-NP O
, , O O
neuropathy NN B-NP O
) -RRB- O O
2. . B-NP O
Hypertension NNP I-NP O
3. . B-NP O
Hyperlipidemia NNP I-NP O
4 CD B-LST O
. . O O
ESRD NNP B-NP O
( -LRB- I-NP O
on IN B-PP O
HD NNP B-NP O
, , O O
s/p JJ B-NP O
AVF NN I-NP O
) -RRB- O O
5 CD B-LST O
. . O O
h/o IN B-PP O
DVT NNP B-NP O
x NN I-NP O
2 CD B-NP O
&amp; NN I-NP O
PE NN I-NP O
x NN I-NP O
1 CD B-NP O
( -LRB- I-NP O
positive JJ I-NP O
lupus NN I-NP O
anticoagulant NN I-NP O
) -RRB- O O
6 CD B-NP O
. . O O
Osteoarthritis NNP O O
7. DT B-NP O
h/o NN I-NP O
bladder NN I-NP O
cancer NN I-NP O
treated VBN B-VP O
by IN B-PP O
"scraping VBG B-NP O
" '' O O
8. . B-NP O
Obesity NN I-NP O
9 CD B-NP O
. . O O
GERD NNP O O
10 CD B-LST O
. . O O
s/p JJR B-NP O
skin NN I-NP O
graft NN I-NP O
from IN B-PP O
hip NN B-NP O
to TO B-PP O
foot NN B-NP O
for IN B-PP O
burn NN B-NP O
11 CD B-LST O
. . O O
s/p IN B-PP O
amputation NN B-NP O
of IN B-PP O
two CD B-NP O
toes NNS I-NP O
on IN B-PP O
R NN B-NP O
foot NN I-NP O
for IN B-PP O
infectionMedications NNS B-NP O
ASA NNP I-NP O
81mg CD I-NP O
PO NN I-NP O
daily RB B-SBAR O
Folic JJ B-NP O
acid NN I-NP O
1mg IN B-PP O
PO NN B-NP O
daily RB B-ADVP O
Gemfibrozil NNP B-NP O
600mg CD I-NP O
PO NNP I-NP O
BID NNP I-NP O
Insulin NNP B-NP O
lantus VBZ B-VP O
50u CD B-NP O
SC NNP I-NP O
QPM NNP I-NP O
Lipitor NNP B-NP O
80mg CD I-NP O
PO NNP I-NP O
QPM NNP I-NP O
Insulin NNP B-NP O
Lispro NNP I-NP O
10-15u CD I-NP O
AC NNP I-NP O
Nephrocaps RB B-NP O
1tab JJ I-NP O
PO NN I-NP O
daily RB O O
Nifedipine JJ B-NP O
ER NNP I-NP O
30mg CD I-NP O
PO NN I-NP O
daily RB B-SBAR O
Phoslo NNP B-NP O
1334mg CD I-NP O
PO NNP I-NP O
TID NN I-NP O
Protonix NNP B-NP O
40mg CD I-NP O
PO NN I-NP O
daily RB B-SBAR O
Soma NNP B-NP O
350mg CD I-NP O
PO NNP I-NP O
QID NNP I-NP O
PRN NNP I-NP O
spasms NNS I-NP O
Viagra NNP B-NP O
100mg CD I-NP O
PO NNP I-NP O
PRN NNP I-NP O
Zetia NNP B-NP O
10mg CD I-NP O
PO NN I-NP O
daily RB B-SBAR O
Toprol NNP B-NP O
XL NNP I-NP O
25mg CD I-NP O
PO NN I-NP O
daily RB B-SBAR O
WarfarinAllergies NNP B-NP O
Codeine NNP I-NP O
, , O O
Cephalosporins NNP B-NP O
, , O O
SimvastatinFamily NNP B-NP O
History NNP I-NP O
Is VBZ B-VP O
remarkable JJ B-ADJP O
for IN B-PP O
father NN B-NP O
at IN B-PP O
81 CD B-NP B-AGE
years NNS I-NP O
of IN B-PP O
age NN B-NP O
who WP B-NP O
has VBZ B-VP O
had VBN I-VP O
breast NN B-NP O
and CC I-NP O
prostate NN I-NP O
cancer NN I-NP O
more RBR B-NP O
than IN I-NP O
15 CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
and CC O O
has VBZ B-VP O
chronic JJ B-NP O
lung NN I-NP O
disease NN I-NP O
currently RB B-ADVP O
. . O O
His PRP$ B-NP O
mother NN I-NP O
died VBD B-VP O
at IN B-PP O
73 CD B-NP B-AGE
years NNS I-NP O
of IN B-PP O
age NN B-NP O
after IN B-PP O
an DT B-NP O
operative JJ I-NP O
intervention NN I-NP O
. . O O
Two CD B-NP O
brothers NNS I-NP O
have VBP B-VP O
been VBN I-VP O
killed VBN I-VP O
by IN B-PP O
shooting VBG B-NP O
, , O O
one CD B-NP O
by IN B-PP O
police NN B-NP O
, , O O
and CC O O
one CD B-NP O
by IN B-PP O
an DT B-NP O
unknown JJ I-NP O
assailant NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
reports VBZ B-VP O
having VBG I-VP O
10 CD B-NP O
children NNS I-NP O
and CC O O
21 CD B-NP O
grandchildren NNS I-NP O
, , O O
three CD B-NP O
of IN B-PP O
his PRP$ B-NP O
children NNS I-NP O
have VBP B-VP O
diabetes NNS B-NP O
.Social JJ B-NP O
History NN I-NP O
Retired VBN B-VP O
on IN B-PP O
disability NN B-NP O
and CC O O
previously RB B-VP O
worked VBN I-VP O
for IN B-PP O
West NNP B-NP B-ORGANIZATION
Liberty NNP I-NP I-ORGANIZATION
Foods NNPS I-NP I-ORGANIZATION
. . O O
He PRP B-NP O
is VBZ B-VP O
not RB I-VP O
married VBN I-VP O
but CC O O
has VBZ B-VP O
been VBN I-VP O
living VBG I-VP O
with IN B-PP O
his PRP$ B-NP O
common-law NN I-NP O
wife NN I-NP O
for IN B-PP O
34 CD B-NP O
years NNS I-NP O
. . O O
Habits '' O O
Tob NNP B-NP O
: : O O
EtOH NNP B-NP O
: : O O
Illicits NNS B-NP O
:Vital NNP I-NP O
Signs NNP I-NP O
T NNP I-NP O
HR NNP I-NP O
BP NNP I-NP O
RR NNP I-NP O
O2 NNP I-NP O
SAT NNP I-NP O
WTPhysical NNP I-NP O
Exam NNP I-NP O
General NNP I-NP O
Appearance NNP I-NP O
NAD NNP I-NP O
, , O O
pleasant JJ B-NP O
, , I-NP O
obese JJ I-NP O
HEENT NNP I-NP O
NC/AT NNP I-NP O
, , O O
PERRL NNP B-NP O
, , O O
EOMI NNP B-NP O
, , O O
arcus NN B-NP O
senilis NNS I-NP O
, , O O
OP NNP B-NP O
clear JJ I-NP O
, , O O
MMMNeck NNP B-NP O
supple NN I-NP O
, , O O
no DT B-NP O
LAD NN I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
no DT B-NP O
bruits NNS I-NP O
, , O O
2+ JJ B-NP O
carotids NNS I-NP O
Chest NNP B-NP O
good JJ I-NP O
inspiratory NN I-NP O
effort NN I-NP O
, , O O
CTAB NNP B-NP O
, , O O
no DT B-NP O
crackles/wheezes NNS I-NP O
Cor/Cardiac NNP I-NP O
RRR NNP I-NP O
, , O O
S1 NNP B-NP O
S2 NNP I-NP O
, , O O
no DT B-NP O
M/R/G NNP I-NP O
, , O O
no DT B-NP O
thrills/lifts/heavesAbdomen NNS I-NP O
+BS RB B-ADVP O
, , O O
S/NT/ND NNP B-NP O
, , O O
no DT B-NP O
hepatomegaly NN I-NP O
, , O O
no DT B-NP O
splenomegaly RB I-NP O
Genito-Urinary JJ I-NP O
DeferredExtremity NN I-NP O
No DT B-NP O
C/C/E NN I-NP O
, , O O
2+ JJ B-NP O
radials NNS I-NP O
, , O O
2+ JJ B-NP O
DP NNP I-NP O
, , O O
2+ CD B-NP O
PTNeurological JJ I-NP O
A&amp;O NNP I-NP O
x NN I-NP O
3 CD B-NP O
( -LRB- I-NP O
place NN I-NP O
, , O O
person NN B-NP O
, , O O
time NN B-NP O
) -RRB- I-NP O
, , I-NP O
face NN I-NP O
symmetric JJ I-NP O
, , I-NP O
fluent JJ I-NP O
speech NN I-NP O
, , O O
moving VBG B-VP O
all DT B-NP O
extremities NNS I-NP O
, , O O
sensation NN B-NP O
grossly RB B-ADVP O
intactSkin IN B-PP O
No DT B-NP O
gross JJ I-NP O
abnormalities NNS I-NP O
Nodes/Lymphatic JJ B-NP O
No DT I-NP O
LADResults NNS I-NP O
3/28 . O B-DATE
INR NN B-NP O
1.6 CD I-NP O
3/27 CD O B-DATE
141/5.3/94/31/8 CD B-NP O
0/11.17/192 CD I-NP O
, , O O
Ca MD O O
9.0 CD O O
ALT NNP B-NP O
13 CD I-NP O
, , O O
AST NNP B-NP O
15 CD I-NP O
, , O O
TBili NNP B-NP O
0.3 CD I-NP O
, , O O
AlkP NNP B-NP O
109 CD I-NP O
CK NNP B-NP O
176 CD I-NP O
7.35&gt JJ B-NP O
;36.3&lt NN I-NP O
;424 . O O
INR NNP B-NP O
1.5Diagnostic CD I-NP O
Testing VBG I-NP O
EKG NNP I-NP O
: : O O
NSR NNP B-NP O
87bpm NN I-NP O
, , O O
no DT B-NP O
ST-T JJ I-NP O
changes NNS I-NP O
(unchanged VBD B-VP O
from IN B-PP O
prior RB B-NP O
) -RRB- O O
Stress NNP B-NP O
PET NNP I-NP O
: : O O
The DT B-NP O
patient NN I-NP O
's POS B-NP O
PET-CT JJ I-NP O
test NN I-NP O
results NNS I-NP O
are VBP B-VP O
abnormal JJ B-ADJP O
and CC I-ADJP O
consistent JJ I-ADJP O
with IN B-PP O
a DT B-NP O
medium NN I-NP O
sized VBD B-VP O
region NN B-NP O
of IN B-PP O
moderate JJ B-NP O
dipyridamole NN I-NP O
induced VBN I-NP O
peprfusion NN I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
distribution NN I-NP O
of IN B-PP O
an DT B-NP O
OM NN I-NP O
coronary JJ I-NP O
artery NN I-NP O
.Assessment NN I-NP O
and CC O O
Plan NNP B-NP O
55 CD I-NP B-AGE
yo NNP I-NP O
M NNP I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
obesity NN B-NP O
, , O O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
hyperlipidemia NN B-NP O
with IN B-PP O
a DT B-NP O
positive JJ I-NP O
pre-operative JJ I-NP O
stress NN I-NP O
test NN I-NP O
now RB B-ADVP O
s/p VBZ B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
. . O O
# # B-NP O
CV NNP I-NP O
( -LRB- O O
I PRP B-NP O
) -RRB- B-VP O
: : O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
abnormal JJ I-NP O
stress NN I-NP O
test NN I-NP O
and CC O O
is VBZ B-VP O
now RB B-ADVP O
s/p JJ B-NP O
cardiac NN I-NP O
cath NN I-NP O
. . O O
- : O O
telemetry NN B-NP O
- : O O
lipids NNS B-NP O
and CC O O
A1c NNP B-NP O
in IN B-LST O
AM VBP O O
- : O O
ASA NNP B-NP O
, , O O
Plavix NNP B-NP O
, , O O
statin NN B-NP O
, , O O
BB NNP B-NP O
- : O O
consider VBP B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-PP O
an DT B-NP O
ACEi NNP I-NP O
especially RB I-NP O
given VBN I-NP O
history NN I-NP O
of IN B-PP O
diabetes NN B-NP O
# # B-NP O
ESRD NNP I-NP O
: : O O
On IN B-NP O
the DT I-NP O
evening NN I-NP O
prior RB B-ADVP O
to TO B-PP O
cath NN B-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
HD NNP B-NP O
and CC I-NP O
will MD B-VP O
have VB I-VP O
HD NNP B-NP O
tomorrow NN B-NP O
. . O O
- : O O
renal JJ B-NP O
aware JJ I-NP O
- : O O
continue VBP B-VP O
phoslo NN B-NP O
, , O O
nephrocaps NNS B-NP O
# # B-NP O
DM NNP I-NP O
: : O O
Last JJ B-NP O
A1c NNP I-NP O
was VBD B-VP O
6.9 CD B-NP O
. . O O
- : O O
check NN B-VP O
A1c NNP B-NP O
in IN B-ADVP O
AM VBP O O
- : O O
Lantus NNP B-NP O
55u CD B-NP O
SC NNP I-NP O
QPM NNP I-NP O
, , O O
Aspart NNP B-NP O
10u CD I-NP O
SC NNP I-NP O
AC NNP I-NP O
, , O O
Aspart NNP B-NP O
SS NNP I-NP O
AC NNP I-NP O
+ NNP I-NP O
HS . O O
# # B-NP O
Hypertension NNP I-NP O
: : O O
- : O O
continue VBP B-VP O
nifedipine NN B-NP O
and CC O O
metoprolol NN B-NP O
# # B-NP O
Hyperlipidemia NNP I-NP O
: : O O
- : O O
check NN B-NP O
lipids NNS I-NP O
in IN B-PP O
AM NNP B-NP O
- : O O
continue VBP B-VP O
lipitor NN B-NP O
, , I-NP O
zetia NN I-NP O
, , O O
gemofibrozil NN B-NP O
# # B-NP O
Osteoarthritis NNP I-NP O
: : O O
Elective JJ B-NP O
surgery NN I-NP O
now RB B-VP O
deferred VBN I-VP O
since IN B-PP O
patient NN B-NP O
is VBZ B-VP O
s/p JJ B-NP O
stent NN I-NP O
and CC B-PP O
on IN B-PP O
necessary JJ B-NP O
Plavix NN I-NP O
- : O O
percocet NN B-NP O
PRN NN I-NP O
- : O O
carisoprodol NN B-NP O
PRN NN I-NP O
# # B-NP O
h/o , O O
DVT NNP B-NP O
: : O O
Currently RB B-ADVP O
on IN B-PP O
Coumadin NNP B-NP O
but CC O O
subtherapeutic JJ B-NP O
. . O O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
8mg JJ B-NP O
PO NNP I-NP O
x NN I-NP O
1 CD I-NP O
in IN B-PP O
the DT B-NP O
cath NN I-NP O
lab NN I-NP O
. . O O
- : O O
follow VB B-VP O
INR NN B-NP O
daily RB B-ADVP O
- : O O
continue VBP B-VP O
home NN B-NP O
Coumadin NN I-NP O
# # B-NP O
FEN NNP I-NP O
: : O O
- : O O
renal/cardiac/diabetic JJ B-NP O
diet NN I-NP O
# # B-NP O
PPX NNP I-NP O
: : O O
- : O O
coumadinContact NN B-NP O
Info NNP I-NP O
Edith NNP I-NP B-PATIENT
Vandiver NNP I-NP I-PATIENT
( -LRB- I-NP O
significant JJ I-NP O
other JJ I-NP O
) -RRB- I-NP O
216-669-9576 CD I-NP B-PHONE
Code NNP I-NP O
Status NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
